Projected Income Statement: Incyte Corporation

Forecast Balance Sheet: Incyte Corporation

Forecast Balance Sheet - Incyte Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -2,348 -3,239 -3,656 -2,158 -3,098 -4,233 -5,800 -7,661
Change - -37.95% -12.87% 40.97% -43.56% -36.64% -37.02% -32.09%
Announcement Date 8/2/22 7/2/23 13/2/24 10/2/25 10/2/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 181 77.83 32.49 86.26 58.87 56.67 68.59 73.57
Change - -57% -58.26% 165.54% -31.76% -3.72% 21.03% 7.25%
Free Cash Flow (FCF) 1 568.5 892.1 464 249.1 - 769.7 1,626 1,739
Change - 56.93% -47.99% -46.32% - - 111.25% 6.97%
Announcement Date 8/2/22 7/2/23 13/2/24 10/2/25 10/2/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 21.55% 17.61% 19.03% 11.86% 33.25% 12.99% 33.92% 31.56%
EBIT Margin (%) 19.62% 17.07% 16.79% 9.76% 31.43% 16.44% 36.13% 38.33%
EBT Margin (%) 19.1% 15.59% 22.57% 7.47% 32.37% 13.72% 33.65% 31.75%
Net margin (%) 31.76% 10.04% 16.17% 0.77% 25.03% 7.66% 24.65% 24.91%
FCF margin (%) 19.04% 26.28% 12.56% 5.87% - 12.7% 25.92% 26.58%
FCF / Net Income (%) 59.93% 261.88% 77.64% 763.68% - 165.84% 105.12% 106.72%

Profitability

        
ROA 22.34% 6.32% 9.47% 3.72% 22.02% 6.88% 18.8% 16.37%
ROE 29.73% 8.37% 12.5% 5.27% 31.7% 10.03% 25.27% 21.39%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 6.06% 2.29% 0.88% 2.03% 1.14% 0.94% 1.09% 1.12%
CAPEX / EBITDA (%) 28.12% 13.02% 4.62% 17.15% 3.44% 7.2% 3.22% 3.56%
CAPEX / FCF (%) 31.84% 8.72% 7% 34.63% - 7.36% 4.22% 4.23%

Items per share

        
Cash flow per share 1 3.375 4.331 2.198 1.593 7.043 3.534 9.88 -
Change - 28.32% -49.26% -27.52% 342.16% -49.83% 179.6% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 16.98 19.62 23.14 17.82 26.04 28.71 38.08 48.02
Change - 15.57% 17.94% -22.97% 46.09% 10.27% 32.61% 26.12%
EPS 1 4.27 1.52 2.65 0.15 6.41 2.253 7.164 7.514
Change - -64.4% 74.34% -94.34% 4,173.33% -64.85% 217.98% 4.89%
Nbr of stocks (in thousands) 220,891 222,475 224,109 192,650 196,323 202,698 202,698 202,698
Announcement Date 8/2/22 7/2/23 13/2/24 10/2/25 10/2/26 - - -
1USD
Estimates
2026 *2027 *
P/E 51.8x 16.3x
PBR 4.07x 3.07x
EV / Sales 3.21x 2.85x
Yield - -

EPS & Dividend

EPS & Dividend - Incyte Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Incyte Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Incyte Corporation
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Incyte Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
116.80USD
Average target price
130.62USD
Spread / Average Target
+11.84%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Incyte Corporation
  1. Stock Market
  2. Stocks
  3. INCY Stock
  4. I1NC34 Stock
  5. Financials Incyte Corporation